Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose
NCT ID: NCT07128485
Last Updated: 2025-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2026-09-30
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
NCT05463341
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000
Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs
NCT03373825
Behavioral Safety and Fentanyl Education: BSAFE
NCT07219082
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
NCT05944952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will use a 2x2 design to cross remote FTS distribution with remote FTS education, thereby isolating the individual and combined effects of the two components. The R61 phase focuses on adapting and piloting the interventions with 100 participants, assessing feasibility, acceptability, and appropriateness. The R33 phase implements a fully powered trial to compare overdose outcomes (fatal and non-fatal) among 2,952 participants randomized to the four study arms, which include: FTS distribution and education, FTS education only, FTS distribution only, and a control group. All groups will receive a resource list for naloxone and FTS. The secondary outcome is FTS knowledge, while exploratory outcomes include behavioral strategies to reduce risk of overdose (including FTS-specific behaviors) and utilization of substance use services engagement and treatment. The study also incorporates ecological momentary assessment to offer insights into daily contextual factors influencing FTS use, as well as a cost-effectiveness analysis to determine the most cost-effective approach with most overdoses averted. The study's 2x2 design allows for a thorough examination of the interactions between FTS distribution and education, identifying the most effective and cost-efficient approach for reducing overdose rates. Overall, findings will inform the scalability of remote overdose prevention interventions. This work represents a sustainable, fully remote model that can be implemented nationwide, setting the stage for transformative advancements in overdose prevention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FDE
This arm receives both FTS distribution (FTS delivered to their residential address) and education (FDE), as well as a resource list for naloxone and additional FTS if desired.
Fentanyl test strips
Fentanyl test strips (FTS) are small strips of paper that can detect the presence of fentanyl in illicit drugs.
Fentanyl test strip education
Developed in the R61 phase, the educational intervention will provide participants with knowledge about how to correctly use fentanyl strips.
E
The Education only (E) arm receives FTS education as well as a resource list for obtaining naloxone and FTS.
Fentanyl test strip education
Developed in the R61 phase, the educational intervention will provide participants with knowledge about how to correctly use fentanyl strips.
FD
The FTS distribution only (FDE) arm receives FTS delivered to their residential address as well as a resource list for obtaining naloxone and additional FTS, if desired.
Fentanyl test strips
Fentanyl test strips (FTS) are small strips of paper that can detect the presence of fentanyl in illicit drugs.
R
The referral only (R) arm receives a resource list for obtaining naloxone and FTS.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fentanyl test strips
Fentanyl test strips (FTS) are small strips of paper that can detect the presence of fentanyl in illicit drugs.
Fentanyl test strip education
Developed in the R61 phase, the educational intervention will provide participants with knowledge about how to correctly use fentanyl strips.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking and reading
* Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST
* Able and willing to provide informed consent
* Reside in any of the US states where fentanyl test strips are legal with no plans to move out of state for at least 12 months
* Reside in any of the US states where FTS are legal with no plans to move out of state for at least 12 months
* Be able and willing to provide the names and contact information of three close contacts to reach if the participant cannot be reached
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emma Kay
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 300015053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.